NCT00150826View on ClinicalTrials.gov

QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Ischemic Heart Disease
Interventions
DRUG

Quinapril

Quinapril will be started at 40mg daily and titrated to 80mg daily for 16 weeks.

DRUG

Placebo

Placebo will be given in a capsule form once daily for 16 weeks.

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Florida

OTHER

NCT00150826 - QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia | Biotech Hunter | Biotech Hunter